Module 1 : Introduction (00:00:00 - 00:08:03)
Dr. Sameeksha Saxena Lamba (PT) from the Medical Learning Hub (MLH) team introduced and welcomed all the panelists and participants. The poll was raised. The structure of the webinar and the general instructions were shared with the participants.
Module 2 : Welcome Address: Dr. Sunil Singhal (00:08:03 - 00:08:59)
Dr. Sunil Singhal, Immediate Past President, IMA EDB welcomed all the panelists and participants. Dr. Singhal shared his insights on the COVID situation in the country and the importance of having CMEs on the same topic. Dr. Singhal also thanked Mylan Pharmaceuticals for making this series of webinars a success.
Module 3 : Effect of COVID reinfections & their manifestation in Cardiology. (00:08:59 - 00:36:31)
Dr. Tapan Ghose, Director & HOD - Department of Cardiology, Fortis Vasant Kunj started his session by thanking the Mylan Pharmaceuticals and MLH team for organizing this webinar. Dr. Ghose covered various topics on the topic such as:
COVID19 Clinical stages.
Clinical features.
Mechanism of Cardiac manifestations of COVID19.
COVID19 Myocarditis.
COVID19 Broken heart syndrome.
Arrhythmias in COVID19.
ECG: COVID19 v/s Non-COVID19 MI.
Echocardiography in COVID19.
Post second wave OPD experience.
COVID19 and Heart: Take home message
All the topics were covered in depth and were well explained.
Module 4 : Effect of COVID reinfections & their manifestation in Endocrinology. (00:36:31 - 01:05:46)
Dr. Alka Jha, MD - Medicine, Speciality Certificate ( Endocrinology & Diabetes MRCP UK) Sr. Consultant - Diabetes and Endocrinology, Fortis Vasant Kunj started her session by thanking IMA EDB, Mylan and MLH for inviting her to the platform as a speaker. Dr. Jha covered various topics on the topic such as:
Endocrine phenotype of COVID19.
Diabetes and COVID19.
Vicious cycle between Diabetes and COVID19.
Are people with uncontrolled Diabetes Mellitus at high risk of reinfections of COVID19.
Potential pathogenic mechanisms in patients with T2DM and COVID 19.
Clinical scenarios of Diabetes management during the COVID19 pandemic.
Guidance for people with Diabetes to prepare for COVID19.
Management of people with Diabetes and COVID19 Recommendations.
COVID19 and other endocrine and metabolic disorders.
Bone and mineral metabolism in COVID19 Hypocalcemia.
All the topics were covered in depth and were well explained.
Module 5 : Q&A (01:05:46 - 01:24:50)
Dr. Sameeksha Saxena Lamba (PT) from the Medical Learning Hub (MLH) team moderated the numerous questions that were asked by the participants throughout the session. All the questions were answered by the speakers and Dr. Gautam Singh, President, IMA EDB. It was an extremely interactive session.
Module 6 : Thank you note (01:24:50 - 01:30:54)
Dr. Gautam Singh, President, IMA EDB thanked all the panelists, Mylan Pharmaceuticals and MLH for this webinar and Dr. Sameeksha Saxena Lamba (PT) from team MLH then thanked Mylan and IMA EDB and Fortis Vasant Kunj for making this webinar a success. The post poll was raised.
We thank Mylan Pharmaceuticals Private Limited, a Viatris Company making this event possible and we wish you all a great learning experience.
- Welcome note: Dr. Gautam Singh, President IMA EDB.
- Speaker 1: Effect of COVID reinfections & their manifestation in Cardiology.
- Speaker 2: Effect of COVID reinfections & their manifestation in Endocrinology.
- Q&A Session: Panelists.
- Vote of Thanks: Dr. Gautam Singh, President IMA EDB.
- Moderator: Dr . Sunil Singhal, Immediate Past President, IMA EDB.
